HIV Tat protein causes endothelial dysfunction in porcine coronary arteries

被引:66
作者
Paladugu, R
Fu, WP
Conklin, BS
Lin, PH
Lumsden, AB
Yao, QZ
Chen, CY
机构
[1] Baylor Coll Med, Michael E DeBakey Dept Surg, Mol Surgeon Res Ctr, Houston, TX 77030 USA
[2] Methodist Hosp, Houston, TX 77030 USA
关键词
D O I
10.1016/S0741-5214(03)00770-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: Human immune deficiency virus (HIV) infection is often associated with chronic diseases, including atherosclerosis. However, the molecular mechanisms are largely unknown. We examined the effect of Tat protein, an HIV regulatory protein, on endothelial function in porcine coronary arteries. Methods. Porcine coronary arteries were dissected from nine pig hearts and cut into 5-mm ring segments, which were incubated as controls or with Tat protein (10(-7), 10(-9), 10(-11) mol/L) or Tat protein plus anti-Tat antibody, for 24 hours. Myography was performed with thromboxane A(2) analog U46619 (10(-7) mol/L) for contraction and with graded doses of bradykinin (10(-8), 10(-7), and 10(-11) mol/L) or sodium nitroprusside (10(-5) mol/L) for relaxation. Endothelial nitric oxide synthase (eNOS) messenger RNA was determined with reverse transcriptase polymerase chain reaction (RT-PCR), and protein levels were determined with Western blot analysis. Immunoreactivity of eNOS of treated rings was also detected. Results. Endothelium-dependent vasorelaxation (10(-7) mol/L of bradykinin) was significantly reduced (46.41%) in pig coronary artery rings treated with 10(-7) mol/L of Tat protein, as compared with control arteries (P < .05). Arteries treated with Tat protein plus anti-Tat antibody relaxed similarly as control arteries. There were no differences in smooth muscle contractility (U46619) or endothelium-independent vasorelaxation (sodium nitroprusside) between control and Tat protein-treated groups. RT-PCR for eNOS mRNA showed reduction in eNOS levels for Tat-treated coronary artery rings by 73%, as compared with control vessels (P < .05). Tat protein-treated vessels demonstrated substantially less eNOS protein band intensity and immunoreactivity compared with control vessels. Conclusions: Tat protein significantly decreased endothelium-dependent vasorelaxation and eNOS mRNA and protein expression in endothelial cells of porcine coronary arteries. This study suggests that Tat protein-mediated endothelial dysfunction may be important in coronary heart disease in HIV-infected patients.
引用
收藏
页码:549 / 555
页数:7
相关论文
共 39 条
[1]   Pilot study of coronary atherosclerotic risk and plaque burden in HIV patients: 'a call for cardiovascular prevention' [J].
Acevedo, M ;
Sprecher, DL ;
Calabrese, L ;
Pearce, GL ;
Coyner, DL ;
Halliburton, SS ;
White, RD ;
Sykora, E ;
Kondos, GT ;
Hoff, JA .
ATHEROSCLEROSIS, 2002, 163 (02) :349-354
[2]   ANGIOGENIC PROPERTIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN [J].
ALBINI, A ;
BARILLARI, G ;
BENELLI, R ;
GALLO, RC ;
ENSOLI, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4838-4842
[3]   Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity [J].
Ansari, SA ;
Safak, M ;
Gallia, GL ;
Sawaya, BE ;
Amini, S ;
Khalili, K .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :2629-2638
[4]   HIV-1 Tat protein stimulates in vivo vascular permeability and lymphomononuclear cell recruitment [J].
Arese, M ;
Ferrandi, C ;
Primo, L ;
Camussi, G ;
Bussolino, F .
JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :1380-1388
[5]   FUNCTIONAL IMPROVEMENT PRECEDES STRUCTURAL REGRESSION OF ATHEROSCLEROSIS [J].
BENZULY, KH ;
PADGETT, RC ;
KAUL, S ;
PIEGORS, DJ ;
ARMSTRONG, ML ;
HEISTAD, DD .
CIRCULATION, 1994, 89 (04) :1810-1818
[6]   CEREBROVASCULAR-DISEASE IN AIDS - A CASE CONTROL STUDY [J].
BERGER, JR ;
HARRIS, JO ;
GREGORIOS, J ;
NORENBERG, M .
AIDS, 1990, 4 (03) :239-244
[7]   Identification of HIV-1 in the aortic wall of AIDS patients [J].
Bobryshev, YV ;
Cherian, SM ;
Inder, SJ ;
Lord, RSA .
ATHEROSCLEROSIS, 2000, 152 (02) :529-530
[8]   Role of nuclear factor-kappa B in atherogenesis [J].
Brand, K ;
Page, S ;
Walli, AK ;
Neumeier, D ;
Baeuerle, PA .
EXPERIMENTAL PHYSIOLOGY, 1997, 82 (02) :297-304
[9]   Interactions between endothelial cells and HIV-1 [J].
Bussolino, F ;
Mitola, S ;
Serini, G ;
Barillari, G ;
Ensoli, B .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (04) :371-390
[10]   HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region [J].
Chang, HC ;
Samaniego, F ;
Nair, BC ;
Buonaguro, L ;
Ensoli, B .
AIDS, 1997, 11 (12) :1421-1431